Survanta

DRUG2 trials

Sponsors

NICHD Neonatal Research Network, Ramesh K Agarwal

Conditions

Bronchopulmonary DysplasiaInfant, Low Birth WeightInfant, NewbornInfant, PrematureInfant, Small for Gestational AgeRespiratory Distress Syndrome

Phase 2

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

CompletedNCT01203358

NICHD Neonatal Research NetworkBronchopulmonary Dysplasia, Infant, Low Birth Weight, Infant, Newborn +2

Start: 1991-01-31End: 1992-01-31Updated: 2019-03-22

Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates

Ramesh K AgarwalRespiratory Distress Syndrome

Start: 2016-06-30End: 2019-05-31Target: 900Updated: 2016-05-17